The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu

Launched by NANJING FIRST HOSPITAL, NANJING MEDICAL UNIVERSITY · Dec 8, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how common Helicobacter Pylori infections are in families living in Jiangsu, China, and whether these infections are resistant to certain antibiotics. Helicobacter Pylori is a bacteria that can cause stomach problems, and understanding how it spreads among family members can help improve treatment options.

To join the study, you need to be part of the community and able to provide a stool sample that meets specific guidelines. Only one person from each family can participate, and everyone must willingly agree and sign a consent form. However, if you have recently taken certain medications or if your stool sample is not suitable, you won't be able to take part in this trial. If you decide to participate, you can expect to provide a stool sample and contribute to important research that may help others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. community population
• • 2. Fecal samples can be obtained, and the sample volume meets the requirements of the collection tube instructions
• • 3. Only one person per family can be selected
• • 4. Voluntarily participated in this study and signed an informed consent form
• Exclusion Criteria:
• • 1. The collector does not cooperate or has poor compliance;
• • 2. Adequate and qualified fecal samples could not be obtained;
• • 3. Stool samples were collected during diarrhea or constipation;
• • 4. Antibiotics, bismuth preparations, proton pump inhibitors and other Hp sensitive drugs have been used within one month.

Trial Officials